CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,521,000 | -7.4% | 60,695 | -51.2% | 0.00% | -50.0% |
| Q3 2021 | $1,642,000 | +0.1% | 124,407 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $1,640,000 | +27.1% | 122,500 | +420.0% | 0.00% | 0.0% |
| Q3 2020 | $1,290,000 | +2.0% | 23,556 | +7.1% | 0.00% | 0.0% |
| Q2 2020 | $1,265,000 | +269.9% | 21,997 | +158.2% | 0.00% | +100.0% |
| Q1 2020 | $342,000 | +66.0% | 8,521 | -72.0% | 0.00% | 0.0% |
| Q3 2019 | $206,000 | -54.2% | 30,394 | -37.2% | 0.00% | 0.0% |
| Q2 2019 | $450,000 | -13.3% | 48,410 | +29.4% | 0.00% | 0.0% |
| Q1 2019 | $519,000 | +641.4% | 37,401 | +482.0% | 0.00% | – |
| Q4 2018 | $70,000 | -68.8% | 6,426 | -63.8% | 0.00% | -100.0% |
| Q3 2018 | $224,000 | +96.5% | 17,754 | +103.5% | 0.00% | – |
| Q2 2018 | $114,000 | +714.3% | 8,724 | +706.3% | 0.00% | -100.0% |
| Q1 2018 | $14,000 | – | 1,082 | +15357.1% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 7 | -98.3% | 0.00% | – |
| Q3 2017 | $3,000 | +200.0% | 422 | +283.6% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 110 | -22.5% | 0.00% | – |
| Q1 2017 | $1,000 | -66.7% | 142 | -79.7% | 0.00% | – |
| Q2 2016 | $3,000 | +200.0% | 701 | +230.7% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 212 | -44.8% | 0.00% | – |
| Q1 2015 | $2,000 | – | 384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |